Showing results (251-260 of 260) with videos related to
Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 260 results.
Preventive Veterinary Medicine|October 26, 1999
Prevalence of herds with young sows seropositive to pseudorabies (Aujeszky's disease) in northern BelgiumF Boelaert, H Deluyker, D Maes, et al.Lancet (London, England)|April 2, 2017
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trialBengt C Fellström, Jonathan Barratt, Heather Cook, et al.Journal of the American Society of Nephrology : JASN|July 12, 2019
Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical SimulationTom Greene, Jian Ying, Edward F Vonesh, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2021
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysisLesley A Inker, Hiddo J L Heerspink, Hocine Tighiouart, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2016
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysisLesley A Inker, Hasi Mondal, Tom Greene, et al.Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2023
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKDWillem Collier, Lesley A Inker, Benjamin Haaland, et al.Nature Medicine|November 6, 2025
A meta-analysis of albuminuria as a surrogate endpoint for kidney failureHiddo J L Heerspink, Willem H Collier, Juhi Chaudhari, et al.Journal of the American Society of Nephrology : JASN|March 15, 2023
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKDHiddo J L Heerspink, Lesley A Inker, Hocine Tighiouart, et al.Nature Medicine|June 17, 2023
A meta-analysis of GFR slope as a surrogate endpoint for kidney failureLesley A Inker, Willem Collier, Tom Greene, et al.Journal of the American Society of Nephrology : JASN|December 4, 2021
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease ProgressionBrendon L Neuen, Hocine Tighiouart, Hiddo J L Heerspink, et al.Pageof 26